Back to
RA CAPITAL MANAGEMENT, L.P.
ASND
Showing 8 of 31 quarters
Position history for
RA CAPITAL MANAGEMENT, L.P.'s holdings in <![CDATA[ASCENDIS PHARMA A/S]]>
As of its Q1 2026 13F, RA Capital Management held 10,281,496 shares of ASND (<![cdata[ascendis Pharma A/S]]>), worth $2.4B. RA Capital Management's 13F filings listed ASND from Q4 2018 to Q1 2026, 30 quarterly filings. ASND was 24.9% of RA Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$1.4B
Total Shares Change
-9.7M
Quarter-by-Quarter History